Simon Campbell on the ups and downs of drug discovery and development

Drug Discovery Today

Volumn 10, Issue 4, 2005, Pages 233-236

  Campbell, Simon ^{a,b,c,d,e,f,g,h}  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b DEPARTAMENTO DE FÍSICA   (Chile)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^f World wide Discovery   (United Kingdom)

^g Royal Society   (United Kingdom)

^h Church Cliff House   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE BESYLATE; ANTIFUNGAL AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE; DOXAZOSIN; FLUCONAZOLE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MALARIA VACCINE; NEW DRUG; PHOSPHODIESTERASE INHIBITOR; ROFECOXIB; SILDENAFIL; ZAPRINAST;

AFRICAN TRYPANOSOMIASIS; DRUG DESIGN; DRUG RESEARCH; DRUG SAFETY; DRUG TOLERABILITY; FINANCIAL MANAGEMENT; HUMAN; MALARIA; NONHUMAN; NOTE; PATENT; SIDE EFFECT;

EID: 13544250620     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(04)03366-5     Document Type: Short Survey

References (0)